In preclinical models of CLL, ROR1 CAR T-cells demonstrated selective toxicity for ROR1 expressing leukemia cells, with rapid clearance of leukemia cells in vivo [58]. The gene discussed is ROR1; the disease is B-cell chronic lymphocytic leukemia.